Replies to post #6955 on Capricor Therapeutics Inc (CAPR)

[quito_yume]

There is no doubt about it ed3. The science is awesome and has broad applicability. Problem is, it will take years for some of that to come to fruition. And all that time they will be selling shares to stay in business. Just for DMD they will need to sell another 60 million shares to stay in business unless they can get a deep pocketed partner or convince the FDA to allow for bypassing or doing an expedited phase III. That's why everyone is so hopeful about the covid treatment and vaccines. If they are successful it could finance their other efforts and the data they obtain from it could help persuade the FDA that exosomes are safe and don't need multi-year trials.